We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$26.1M
2
RTN
Raytheon Company
RTN
+$22.2M
3
ABT icon
Abbott
ABT
+$20.8M
4
ELLI
Ellie Mae Inc
ELLI
+$19.9M
5
BURL icon
Burlington
BURL
+$19.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBS icon
576
Sabesp
SBS
$19.7B
$96K ﹤0.01%
53,550
-1,135
-2% -$2.01K
FCFP
577
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$95K ﹤0.01%
10,000
– –
RAD
578
DELISTED
Rite Aid Corporation
RAD
$82K ﹤0.01%
535
-320
-37% -$47.8K
FTR
579
DELISTED
Frontier Communications Corp.
FTR
$82K ﹤0.01%
1,318
+553
+72% +$39.4K
SIRI icon
580
SiriusXM
SIRI
$10B
$72K ﹤0.01%
1,720
-200
-10% -$8.35K
SCU
581
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$70K ﹤0.01%
1,609
-180
-10% -$6.79K
OIL
582
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$68K ﹤0.01%
+11,700
New +$65.9K
ECT
583
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$66K ﹤0.01%
30,000
– –
CPSS icon
584
Consumer Portfolio Services
CPSS
$205M
$64K ﹤0.01%
14,000
– –
SDRL
585
DELISTED
Seadrill Limited Common Stock
SDRL
$57K ﹤0.01%
+90
New +$64.6K
AKS
586
DELISTED
AK Steel Holding Corp
AKS
$52K ﹤0.01%
10,865
+865
+9% +$4.39K
ELI
587
DELISTED
ELITE PHARMACEUTICAL
ELI
$52K ﹤0.01%
293,180
– –
GNW icon
588
Genworth Financial
GNW
$3.8B
$50K ﹤0.01%
10,000
– –
DHT icon
589
DHT Holdings
DHT
$2.97B
$42K ﹤0.01%
+10,000
New +$46.5K
PLM
590
DELISTED
PolyMet Mining Corp.
PLM
$39K ﹤0.01%
4,910
– –
NAGE
591
Niagen Bioscience
NAGE
$256M
$30K ﹤0.01%
+10,000
New +$36.7K
ARNA
592
DELISTED
Arena Pharmaceuticals Inc
ARNA
$18K ﹤0.01%
1,000
– –
BLPH
593
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$18K ﹤0.01%
833
– –
DNN icon
594
Denison Mines
DNN
$2.63B
$12K ﹤0.01%
25,000
– –
BKF
595
DELISTED
BKF CAPITAL GROUP,INC
BKF
$11K ﹤0.01%
17,000
– –
CMLS
596
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$10K ﹤0.01%
3,750
– –
GPIC
597
DELISTED
Gaming Partners International Corporation
GPIC
$9K ﹤0.01%
1,248,500
– –
QMM
598
DELISTED
QUATERRA RESOURCES INC LTD
QMM
$8K ﹤0.01%
136,175
– –
GMO
599
DELISTED
General Moly, Inc.
GMO
$4K ﹤0.01%
13,518
– –
AEE icon
600
Ameren
AEE
$31.5B
– –
-4,008
Closed -$215K
22 23
24
25 26

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.